Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 9, 1997, Pages 1973-1978

  Zeller, Valerie ^a   Janoir, Claire ^a   Kitzis, Marie Dominique ^b   Gutmann, Laurent ^a   Moreau, Nicole J ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b SAINT JOSEPH HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIFLAVINE; BAYER Y3118; BENZALKONIUM CHLORIDE; CETRIMIDE; CHLORAMPHENICOL; CIPROFLOXACIN; ETHIDIUM BROMIDE; LEVOFLOXACIN; NOVOBIOCIN; OFLOXACIN; PEFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN; TETRACYCLINE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MEMBRANE; DRUG TRANSPORT; MEMBRANE TRANSPORT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

EID: 0030805166     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.9.1973     Document Type: Article

References (38)

1. Alloing, G., M.-C. Trombe, and J.-P. Claverys. 1990. The ami locus of the gram-positive bacterium Streptococcus pneumoniae is similar to binding protein-dependent transport operons of gram-negative bacteria. Mol. Microbiol. 4:633-644.
2. Ball, P. 1990. Emergent resistance to ciprofloxacin amongst Pseudomonas aeruginosa and Staphylococcus aureus: clinical significance and therapeutic approaches. J. Antimicrob. Chemother. 26(Suppl. F):165-179.
3. Barry, A. L., P. C. Fuchs, and S. D. Brown. 1996. In vitro activities of five fluoroquinolone compounds against Streptococcus pneumoniae with resistance to other antimicrobial agents. Antimicrob. Agents Chemother. 40: 2431-2433.
4. Bazile, S., N. J. Moreau, D. Bouzard, and M. Essiz. 1992. Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones. Antimicrob. Agents Chemother. 36: 2622-2627.
5. Bernard, L., J.-C. Nguyen Van, and J.-L. Mainardi. 1994. In vivo selection of Streptococcus pneumoniae, resistant to quinolones, including sparfloxacin. Clin. Microbiol. Infect. 1:60-61.
6. Bolhuis, H., D. Molenaar, G. Poelarends, H. van Veen, B. Poolman, A. J. M. Driessen, and W. N. Konings. 1994. Proton motive force-driven and ATP-dependent drug extrusion systems in multidrug-resistant Lactococcus lactis. J. Bacteriol. 176:6957-6964.
7. Bolhuis, H., H. W. van Veen, J. R. Brands, M. Putman, B. Poolman, A. J. M. Driessen, and W. N. Konings. 1996. Energetics and mechanism of drug transport mediated by the lactococcal multidrug transporter LmrP. J. Biol. Chem. 271:24123-24128.
8. Canton, E., J. Peman, M. T. Jimenez, M. S. Ramon, and M. Gobernado. 1992. In vitro activity of sparfloxacin compared with those of five other quinolones. Antimicrob. Agents Chemother. 36:558-565.
9. Charvalos, E., Y. Tselentis, M. M. Hamzehpour, T. Köhler, and J.-C. Péchère. 1995. Evidence for an efflux pump in multidrug-resistant Campylobacter jejuni. Antimicrob. Agents Chemother. 39:2019-2022.
10. Denis, A., and N. J. Moreau. 1993. Mechanisms of quinolone resistance in clinical isolates: accumulation of sparfloxacin and of fluoroquinolones of various hydrophobicity, and analysis of membrane composition. J. Antimicrob. Chemother. 32:379-392.
11. Furet, Y., J. Deshusses, and J.-C. Péchère. 1992. Transport of pefloxacin across the bacterial cytoplasmic membrane in quinolone-susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 36:2506-2511.
12. George, A. M., R. M. Hall, and H. W. Stokes. 1995. Multidrug resistance in Klebsiella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli. Microbiology 141:1909-1920.
13. ++ in Streptococcus. Mol. Cell. Biochem. 44:81-106.
14. Hofmann, J., M. S. Cetron, M. M. Farley, W. S. Baughman, R. R. Facklam, J. A. Elliott, K. A. Deaver, and R. F. Breiman. 1995. The prevalence of drug-resistant Streptococcus pneumoniae in Atlanta. N. Engl. J. Med. 333: 481-486.
15. Hui, F. M., and D. A. Morrison. 1991. Genetic transformation in Streptococcus pneumoniae: nucleotide sequence analysis shows comA, a gene required for competence induction, to be a member of the bacterial ATP-dependent transport protein family. J. Bacteriol. 173:372-381.
16. Janoir, C., V. Zeller, M.-D. Kitzis, N. J. Moreau, and L. Gutmann. 1996. High-level fluoroquinolone resistance in Streptococcus pneumoniae requires mutations in parC and gyrA. Antimicrob. Agents Chemother. 40:2760-2764.
17. Janoir, C., V. Zeller, M.-D. Kitzis, and L. Gutmann. 1996. GyrA mutations in in-vitro selected and clinical fluoroquinolone-resistant strains of Streptococcus pneumoniae, abstr. C2, p. 34. In Program and abstracts of the 36th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
18. Kaatz, G. W., S. M. Seo, and C. A. Ruble. 1993. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 37:1086-1094.
19. Kaatz, G. W., and S. M. Seo. 1995. Inducible NorA-mediated multidrug resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 39: 2650-2655.
20. Lafredo, S. C., B. D. Foleno, and K. P. Fu. 1993. Induction of resistance of Streptococcus pneumoniae to quinolones in vitro. Chemotherapy (Basel) 39:36-39.
21. Li, X.-Z., D. M. Livermore, and H. Nikaido. 1994. Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin. Antimicrob. Agents Chemother. 38:1732-1741.
22. Malmborg, A.-S., and S. Ahlén. 1993. In vitro activity of sparfloxacin compared with ciprofloxacin and ofloxacin against respiratory tract pathogens. Chemotherapy (Basel) 39:32-35.
23. Munoz, R., and A. G. de la Campa. 1996. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype. Antimicrob. Agents Chemother. 40:2252-2257.
24. Neyfakh, A. A. 1992. The multidrug efflux transporter of Bacillus subtilis is a structural and functional homolog of the Staphylococcus NorA protein. Antimicrob. Agents Chemother. 36:484-485.
25. Ng, E. Y. W., M. Trucksis, and D. C. Hooper. 1994. Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome. Antimicrob. Agents Chemother. 38:1345-1355.
26. Nikaido, H., and D. G. Thanassi. 1993. Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples. Antimicrob. Agents Chemother. 37:1393-1399.
27. Nikaido, H. 1994. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 264:382-388.
28. Ottolenghi, E., and R. D. Hotchkiss. 1962. Release of genetic transforming agent from pneumococcal cultures during growth and disintegration. J. Exp. Med. 116:491-519.
29. Pallares, R., J. Linares, M. Vadillo, C. Cabellos, F. Manresa, P. F. Viladrich, R. Martin, and F. Gudiol. 1995. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333:474-480.
30. Pan, X.-S., and L. M. Fisher. 1996. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance. J. Bacteriol. 178:4060-4069.
31. Pan, X.-S., J. Ambler, S. Mehtar, and L. M. Fisher. 1996. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 40:2321-2326.
32. Ross, D. L., and C. N. Riley. 1992. Physicochemical properties of the fluoroquinolones antimicrobials. Int. J. Pharm. 88:379-389.
33. Sutcliffe, J., A. Tait-Kamradt, and L. Wondrack. 1996. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob. Agents Chemother. 40:1817-1824.
34. Trombe, M.-C., G. Lanéelle, and A. M. Sicard. 1984. Characterization of a Streptococcus pneumoniae mutant with altered electric transmembrane potential. J. Bacteriol. 158:1109-1114.
35. Trucksis, M., D. C. Hooper, and J. S. Wolfson. 1991. Emerging resistance to fluoroquinolones in staphylococci: an alert. Ann. Intern. Med. 114:424-426.
36. Van Veen, H. W., K. Venema, H. Bolhuis, I. Oussenko, J. Kok, B. Poolman, A. J. N. Driessen, and W. N. Konings. 1996. Multidrug resistance mediated by bacterial homolog of the human multidrug transporter MDR1. Proc. Natl. Acad. Sci. USA 93:10668-10672.
37. Yoshida, H., M. Bogaki, S. Nakamura, K. Ubukata, and M. Konno. 1990. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J. Bacteriol. 172:6942-6949.
38. Yoshida, S., T. Kojima, M. Inoue, and S. Mitsuhashi. 1991. Uptake of sparfloxacin and norfloxacin by clinical isolates of Staphylococcus aureus. Antimicrob. Agents Chemother. 35:368-370.